October 14, 2004
FDA approves Abilify
Bristol-Myers Squibb and Otsuka Pharmaceutical Company won FDA approval for Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Brands should refrain from tweets that are over 100 characters, according to Twitter's director of brand strategy.